can tirzepatide cause vision loss Weight medications may blurry Ophthalmic complications observed in patients

Hypoglycemiablood glucose below 70 mg/dLoccurs most commonly in patients using semaglutide in combination with insulin injections or sulfonylurea drugs like glyburide or glipizide

Peptides are some of the most versatile tools in medicine today

Assessing the main degradation protein dipeptidyl peptidase 4 (DPP4) no significant association with either GLP-1 or -2 could be found

Table of Contents Understanding GLP-1 Therapy in Type 1 Diabetes Potential Benefits and Clinical Outcomes Risks, Safety Concerns, and Limitations Patient Selection and Practical Considerations Understanding GLP-1 Therapy in Type 1 Diabetes GLP-1 receptor agonists are well established in type 2 diabetes, yet their role in type 1 diabetes remains off-label

Given the mixed findings so far, further investigation into patient selection and specific GLP-1 analogs might help identify which populations could benefit most from this therapeutic approach